For PCSK9, no significant association with CRC was found in the only other MR study identified (797 events, 0.40; 0.14-1.19 per 1 mmol/L decrease in LDL-C) [20], and no relevant RCT or meta-analysis of cohort studies was identified. This evidence concerns the gene PCSK9 and colorectal carcinoma.